SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062139
Filing Date
2023-11-09
Accepted
2023-11-09 16:30:38
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vera-20230930.htm   iXBRL 10-Q 2862747
2 EX-31.1 vera-ex31_1.htm EX-31.1 17969
3 EX-31.2 vera-ex31_2.htm EX-31.2 17938
4 EX-32.1 vera-ex32_1.htm EX-32.1 10652
5 EX-32.2 vera-ex32_2.htm EX-32.2 10896
  Complete submission text file 0000950170-23-062139.txt   8647304

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vera-20230930_cal.xml EX-101.CAL 48628
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vera-20230930.xsd EX-101.SCH 55745
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vera-20230930_pre.xml EX-101.PRE 312747
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vera-20230930_lab.xml EX-101.LAB 423356
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vera-20230930_def.xml EX-101.DEF 229835
61 EXTRACTED XBRL INSTANCE DOCUMENT vera-20230930_htm.xml XML 1363640
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40407 | Film No.: 231393077
SIC: 2834 Pharmaceutical Preparations